therapeuticЮжно-Российский журнал терапевтической практикиSouth Russian Journal of Therapeutic Practice2712-8156РостГМУ10.21886/2712-8156-2024-5-1-23-31therapeutic-489Research ArticleОБЗОРЫREVIEWSНарушения мочеиспускания при рассеянном склерозеUrinary dysfunction in multiple sclerosishttps://orcid.org/0009-0006-0252-2752АбдуллахНемер М.Н.AbdallaxNemer M.N.

Абдуллах Немер М.Н., аспирант кафедры урологии и репродуктивного здоровья человека (с курсом детской урологии-андрологии)

Ростов-на-Дону

Abdallax Nemer M.N., postgraduate student (PhD) of the Department of Urology and Human Reproductive Health (with a course of pediatric Urology-Andrology)

Rostov-on-Don

n_m2015@live.comhttps://orcid.org/0000-0003-0674-9429БелоусовИ. И.BelousovI. I.

Белоусов Игорь Иванович, д.м.н., доцент, профессор кафедры урологии и репродуктивного здоровья человека (с курсом детской урологии-андрологии)

Ростов-на-Дону

Belousov Igor I., Dr. Sci. (Med.), Professor of the Department of Urology and Human Reproductive Health (with a course of pediatric Urology-Andrology)

Rostov-on-Don

belrost_dept@mail.ruhttps://orcid.org/0000-0001-7093-9548ГончароваЗ. А.GoncharovaZ. A.

Гончарова Зоя Александровна, д.м.н., доцент, профессор кафедры нервных болезней и нейрохирургии, ФГБОУ ВО «Ростовский государственный медицинский университет» Минздрава России, заведующая центром неврологическим Клиники ФГБОУ ВО РостГМУ Минздрава России

Ростов-на-Дону

Goncharova Zoya A., Dr. Sci. (Med.), Professor of the Department of Nervous Diseases and Neurosurgery, Rostov State Medical University, Head of the Neurological Center of the Clinic of the Rostov State Medical University

Rostov-on-Don

centrms@mail.ruhttps://orcid.org/0000-0003-1958-9858ИсмаиловР. С.IsmailovR. S.

Исмаилов Руслан Самедович, к.м.н, ассистент кафедры урологии и репродуктивного здоровья человека (с курсом детской урологии-андрологии)

Ростов-на-Дону

Ismailov Ruslan S., Cand. Sci. (Med.), assistant of the Department of Urology and Human Reproductive Health (with a course of pediatric Urology-Andrology)

Rostov-on-Don

dr.ruslan.ismailov@gmail.comhttps://orcid.org/0009-0000-0220-1656РуденкоО. Ю.RudenkoO. Yu.

Руденко Ольга Юрьевна, к.м.н., ассистент кафедры нервных болезней и нейрохирургии

Ростов-на-Дону

Rudenko Olga Yu., Cand. Sci. (Med.), assistant of the Department of Nervous Diseases and Neurosurgery

Rostov-on-Don

olyt@rambler.ruhttps://orcid.org/0009-0003-0103-0412ПчелкинА. С.PchelkinA. S.

Пчелкин Артем Сергеевич, студент 6 курса лечебно-профилактического факультета

Ростов-на-Дону

Pchelkin Artem S., 6th year student, Faculty of General Medicine

Rostov-on-Don

pchelkin131@mail.ruФГБОУ ВО «Ростовский государственный медицинский университет» Минздрава РоссииРоссияRostov State Medical UniversityRussian Federation202429032024512331Copyright © Абдуллах Н.М., Белоусов И.И., Гончарова З.А., Исмаилов Р.С., Руденко О.Ю., Пчелкин А.С., 20242024Абдуллах Н.М., Белоусов И.И., Гончарова З.А., Исмаилов Р.С., Руденко О.Ю., Пчелкин А.С.Abdallax N.M., Belousov I.I., Goncharova Z.A., Ismailov R.S., Rudenko O.Y., Pchelkin A.S.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therapeutic-j.ru/jour/article/view/489

В настоящем обзоре представлена актуальность обязательной оценки функции нижних мочевых путей при рассеянном склерозе для выявления симптомов со стороны нижних мочевых путей, характера и выраженности инвалидизации пациентов относительно нарушений мочеиспускания. Симптомы нижних мочевых путей при рассеянном склерозе многообразны и соотносятся с фазами миктурического цикла. Нарушения акта мочеиспускания при рассеянном склерозе наиболее часто представлены императивными позывами к мочеиспусканию или спорадическими эпизодами задержки мочеиспускания. При прогрессировании заболевания наряду с императивностью и сенсорными нарушениями формируется недержание мочи, результирующее до тотального недержания мочи в наиболее тяжёлых случаях. Также может формироваться хроническая ретенция мочи, что определяет необходимость отведения мочи из мочевого пузыря посредством уретрального дренирования. В свою очередь существенно повышается риск развития инфекции мочевых путей, в том числе катетер-ассоциированной.

This review presents the relevance of mandatory assessment of the function of the lower urinary tract in multiple sclerosis to identify the lower urinary tract symptoms, the nature and severity of disability in patients regarding urinary disorders. Lower urinary tract symptoms in multiple sclerosis are diverse and correlate with the phases of the urination cycle. lower urinary tract symptoms in multiple sclerosis include urinary urgency or sporadic episodes of urinary retention. As the disease progresses, along with urgency and sensory disturbances, urinary incontinence develops, resulting in total urinary incontinence in the most severe cases. Chronic urine retention may also form, which determines the need to urine diversion from the bladder through urethral drainage. In turn, the risk of developing urinary tract infections, including catheter-associated ones, increases significantly.

рассеянный склерознарушения мочеиспусканиясимптомы нижних мочевых путейнейрогенная дисфункция нижних мочевых путейmultiple sclerosisurinary disorderslower urinary tract symptomsneurogenic dysfunction of the lower urinary tractReferencesMontalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Eur J Neurol. 2018;25(2):215-237. Erratum in: Eur J Neurol. 2018;25(3):605. PMID: 29352526. DOI: 10.1111/ene.13536.Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Eur J Neurol. 2018;25(2):215-237. Erratum in: Eur J Neurol. 2018;25(3):605. PMID: 29352526. DOI: 10.1111/ene.13536.Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(17):777-788. Erratum in: Neurology. 2019;92(2):112. DOI: 10.1212/WNL.0000000000005347.Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(17):777-788. Erratum in: Neurology. 2019;92(2):112. DOI: 10.1212/WNL.0000000000005347.Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011;9(3):409-416. DOI: 10.2174/157015911796557911Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011;9(3):409-416. DOI: 10.2174/157015911796557911Boyko A, Smirnova N, Petrov S, Gusev E. Epidemiology of MS in Russia, a historical review. Mult Scler Demyelinating Disord. 2016;13:1. DOI: 10.1186/s40893-016-0016-9Boyko A, Smirnova N, Petrov S, Gusev E. Epidemiology of MS in Russia, a historical review. Mult Scler Demyelinating Disord. 2016;13:1. DOI: 10.1186/s40893-016-0016-9Бойнова И.В., Самарина Д.В., Каторова А.В., Токарева Н.Г. Клинико-эпидемиологические особенности рассеянного склероза в Российской Федерации. Современные проблемы науки и образования. 2022;(5):138.Boynova I.V., Samarina D.V., Katorova A.V., Tokareva N.G. Clinical and epidemiological features of multiple sclerosis in the Russian Federation. Modern problems of science and education. 2022;(5):138. (In Russ.) DOI: 10.17513/spno.32006Boyko A, Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies. Brain Sci. 2020;10(5):305.Boyko A, Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies. Brain Sci. 2020;10(5):305. DOI: 10.3390/brainsci10050305DOI: 10.3390/brainsci10050305Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31(6):752-759. DOI: 10.1097/WCO.0000000000000622Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31(6):752-759. DOI: 10.1097/WCO.0000000000000622Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-86. DOI: 10.1212/WNL.0000000000000560Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-86. DOI: 10.1212/WNL.0000000000000560Hartung HP, Graf J, Aktas O, Mares J, Barnett MH. Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change. Curr Opin Neurol. 2019;32(3):327-337. DOI: 10.1097/WCO.0000000000000699Hartung HP, Graf J, Aktas O, Mares J, Barnett MH. Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change. Curr Opin Neurol. 2019;32(3):327-337. DOI: 10.1097/WCO.0000000000000699Sakakibara R. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. Clin Auton Res. 2019;29(3):313-320. DOI: 10.1007/s10286-018-0551-xSakakibara R. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. Clin Auton Res. 2019;29(3):313-320. DOI: 10.1007/s10286-018-0551-xCastel-Lacanal E, Gamé X, Clanet M, Gasq D, De Boissezon X, Guillotreau J, Bourg V, Viala F, Rischmann P, Marque P. Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients. Neurourol Urodyn. 2015;34(1):32-36. DOI: 10.1002/nau.22495Castel-Lacanal E, Gamé X, Clanet M, Gasq D, De Boissezon X, Guillotreau J, Bourg V, Viala F, Rischmann P, Marque P. Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients. Neurourol Urodyn. 2015;34(1):32-36. DOI: 10.1002/nau.22495Zecca C, Riccitelli GC, Disanto G, Singh A, Digesu GA, Panicari L, et al. Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life. Eur J Neurol. 2016;23(7):1228-1234. DOI: 10.1111/ene.13010Zecca C, Riccitelli GC, Disanto G, Singh A, Digesu GA, Panicari L, et al. Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life. Eur J Neurol. 2016;23(7):1228-1234. DOI: 10.1111/ene.13010Inojosa H, Schriefer D, Ziemssen T. Clinical outcome measures in multiple sclerosis: A review. Autoimmun Rev. 2020;19(5):102512. DOI: 10.1016/j.autrev.2020.102512Inojosa H, Schriefer D, Ziemssen T. Clinical outcome measures in multiple sclerosis: A review. Autoimmun Rev. 2020;19(5):102512. DOI: 10.1016/j.autrev.2020.102512Nazari F, Shaygannejad V, Mohammadi Sichani M, Mansourian M, Hajhashemi V. The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis. BMC Neurol. 2020;20(1):24. DOI: 10.1186/s12883-019-1582-1Nazari F, Shaygannejad V, Mohammadi Sichani M, Mansourian M, Hajhashemi V. The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis. BMC Neurol. 2020;20(1):24. DOI: 10.1186/s12883-019-1582-1Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453-466. DOI: 10.1038/nrn2401Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453-466. DOI: 10.1038/nrn2401Ramagopalan SV, Ebers GC. Genes for multiple sclerosis. Lancet. 2008;371(9609):283-285. DOI: 10.1016/S0140-6736(08)60145-2. PMID: 18294983.Ramagopalan SV, Ebers GC. Genes for multiple sclerosis. Lancet. 2008;371(9609):283-285. DOI: 10.1016/S0140-6736(08)60145-2. PMID: 18294983.Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol. 2007;64(1):76-80. DOI: 10.1001/archneur.64.1.76Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol. 2007;64(1):76-80. DOI: 10.1001/archneur.64.1.76Schmierer K, McDowell A, Petrova N, Carassiti D, Thomas DL, Miquel ME. Quantifying multiple sclerosis pathology in post mortem spinal cord using MRI. Neuroimage. 2018;182:251-258. DOI: 10.1016/j.neuroimage.2018.01.052Schmierer K, McDowell A, Petrova N, Carassiti D, Thomas DL, Miquel ME. Quantifying multiple sclerosis pathology in post mortem spinal cord using MRI. Neuroimage. 2018;182:251-258. DOI: 10.1016/j.neuroimage.2018.01.052Ramasamy R, Smith PP. Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research. Neurourol Urodyn. 2021;40(4):950-957. DOI: 10.1002/nau.24649Ramasamy R, Smith PP. Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research. Neurourol Urodyn. 2021;40(4):950-957. DOI: 10.1002/nau.24649Sparaco M, Bonavita S. Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis. J Clin Med. 2022;11(7):1941. DOI: 10.3390/jcm11071941Sparaco M, Bonavita S. Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis. J Clin Med. 2022;11(7):1941. DOI: 10.3390/jcm11071941Al Dandan HB, Coote S, McClurg D. Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis. Int J MS Care. 2020;22(2):91-99. DOI: 10.7224/1537-2073.2019-030Al Dandan HB, Coote S, McClurg D. Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis. Int J MS Care. 2020;22(2):91-99. DOI: 10.7224/1537-2073.2019-030de Sèze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B; GENULF. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13(7):915-928. DOI: 10.1177/1352458506075651de Sèze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B; GENULF. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13(7):915-928. DOI: 10.1177/1352458506075651Seddone S, Marturano M, Bientinesi R, Lucchini M, Bassi P, Mirabella M, Nociti V. Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments. Neurourol Urodyn. 2021;40(6):1500-1508. DOI: 10.1002/nau.24687Seddone S, Marturano M, Bientinesi R, Lucchini M, Bassi P, Mirabella M, Nociti V. Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments. Neurourol Urodyn. 2021;40(6):1500-1508. DOI: 10.1002/nau.24687Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187(1):116-126. DOI: 10.1067/mob.2002.125704Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187(1):116-126. DOI: 10.1067/mob.2002.125704Faithfull S, Lemanska A, Aslet P, Bhatt N, Coe J, Drudge-Coates L, et al. Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies. Int J Clin Pract. 2015;69(10):1184-1208. DOI: 10.1111/ijcp.12693Faithfull S, Lemanska A, Aslet P, Bhatt N, Coe J, Drudge-Coates L, et al. Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies. Int J Clin Pract. 2015;69(10):1184-1208. DOI: 10.1111/ijcp.12693D'Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433-477. DOI: 10.1002/nau.23897D'Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433-477. DOI: 10.1002/nau.23897Amarenco G, de Sèze M, Ruffion A, Sheikh Ismael S. Clinical and urodynamic evaluations of urinary disorders in multiple sclerosis. Ann Phys Rehabil Med. 2014;57(5):277-287. DOI: 10.1016/j.rehab.2014.05.006Amarenco G, de Sèze M, Ruffion A, Sheikh Ismael S. Clinical and urodynamic evaluations of urinary disorders in multiple sclerosis. Ann Phys Rehabil Med. 2014;57(5):277-287. DOI: 10.1016/j.rehab.2014.05.006Ziryanov A.V., Bazhenov I.V., Philippova E.S., Ustinov G.S., Turova E.L., Toreyev I.O., et al. Epidemiology and characteristics of urinary tract dysfunction in multiple sclerosis patients. Urology Herald. 2020;8(2):29-36. (In Russ.) DOI: 10.21886/2308-6424-2020-8-2-29-36Зырянов А.В., Баженов И.В., Филиппова Е.С., Устинов Г.С., Турова Е.Л., Тореев И.О., и др. Эпидемиология и характер расстройств мочеиспускания у больных рассеянным склерозом. Вестник урологии. 2020;8(2):29-36.Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6):988-1000. DOI: 10.1016/j.eururo.2019.02.038Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6):988-1000. DOI: 10.1016/j.eururo.2019.02.038Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agrò EF, et al. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn. 2018;37(3):1152-1161. DOI: 10.1002/nau.23397Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agrò EF, et al. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn. 2018;37(3):1152-1161. DOI: 10.1002/nau.23397Rahnama'i MS. Neuromodulation for functional bladder disorders in patients with multiple sclerosis. Mult Scler. 2020;26(11):1274-1280. DOI: 10.1177/1352458519894714Rahnama'i MS. Neuromodulation for functional bladder disorders in patients with multiple sclerosis. Mult Scler. 2020;26(11):1274-1280. DOI: 10.1177/1352458519894714Qin C, Wang Y, Gao Y. Overactive Bladder Symptoms Within Nervous System: A Focus on Etiology. Front Physiol. 2021;12:747144. DOI: 10.3389/fphys.2021.747144Qin C, Wang Y, Gao Y. Overactive Bladder Symptoms Within Nervous System: A Focus on Etiology. Front Physiol. 2021;12:747144. DOI: 10.3389/fphys.2021.747144Shvarts P.G., Dutov V.V. Polymorphism of the syndrome of hyperactive urinary bladder in patients with acute and chronic vascular diseases of the brain. Urology Herald. 2016;(3):41-60. (In Russ.) DOI: 10.21886/2308-6424-2016-0-3-41-60Шварц П.Г., Дутов В.В. Полиморфизм синдрома гиперактивного мочевого пузыря у пациентов с острыми и хроническими сосудистыми заболеваниями головного мозга. Вестник урологии. 2016;(3):41-60.Vieira B, Costa A, Videira G, Sá MJ, Abreu P. Prevalence of autonomic dysfunction in patients with multiple sclerosis. Acta Med Port. 2015;28(1):51-55. DOI: 10.20344/amp.5562Vieira B, Costa A, Videira G, Sá MJ, Abreu P. Prevalence of autonomic dysfunction in patients with multiple sclerosis. Acta Med Port. 2015;28(1):51-55.Vieira B, Costa A, Videira G, Sá MJ, Abreu P. Prevalence of autonomic dysfunction in patients with multiple sclerosis. Acta Med Port. 2015;28(1):51-55.DOI: 10.20344/amp.5562DOI: 10.20344/amp.5562

The authors declare that there are no conflicts of interest present.